dRhnse6IwVY https://histock.tw/talk/live.aspx?name=gtalk&id=1279 20240605 阿布波

台股 » 個股 » 中化生 » 籌碼相關 » 券商分點績效

中化生

(1762)
可現股當沖
  • 股價
    48.05
  • 漲跌
    ▲0.25
  • 漲幅
    +0.52%
  • 成交量
    100
  • 產業
    上市 生技醫療類股
  • 251人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
中化生 (1762)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/03/26     後一日»

券商獲利排行 - 2024/03/26

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  2.57%1270127-100010049.3049.348.1
  2.73%27027-2002049.4049.448.1
  1.35%23.4-1.424.8-19163549.449.449.448.1
  2.14%21.1-0.121.1-1812049.249.249.248.1
  2.91%17.3017.3-1101249.549.549.548.1
  3.32%16.5016.5-901049.749.549.748.1
  1.62%15.9-0.916.8-1642049.149.349.148.1
  1.94%9.509.5-100104904948.1
  2.14%6.306.3-60649.1049.148.1
  3.90%5.905.9-2035049.35048.1
  2.16%4.304.3-30449.149.749.148.1
  4.00%404-1025049.950.148.1
  2.63%3.903.9-30349.4049.448.1
  0.94%3.30.92.3-25749.14949.248.1
  2.49%2.502.5-20249.3049.348.1
  1.66%2.5-0.12.5-21349.349.449.348.1
  1.44%2.102.1-20348.849.348.848.1
  2.09%2.102.1-20249.1049.148.1
  1.37%202-30348.7048.748.1
  1.02%2-0.52.5-3144949.448.948.1
  1.84%1.801.8-2024904948.1
  3.42%1.701.7-10149.8049.848.1
  1.54%1.501.5-20248.8048.848.1
  2.93%1.501.5-10149.5049.548.1
  2.73%1.401.4-10149.4049.448.1
  2.73%1.401.400149.449.249.448.1
  2.14%1.101.100149.150.249.148.1
  2.14%1.101.1-10149.1049.148.1
  2.14%1.101.100149.149.249.148.1
  2.14%1.101.1-10149.1049.148.1
  2.04%10100149.149.949.148.1
  1.84%0.900.90014949.84948.1
  1.44%0.700.7-10148.8048.848.1
   00000049.549.5048.1
   00000050.450.4048.1
   00000049.949.9048.1
   00000050.250.2048.1
   00000049.349.3048.1
   00000049.349.3048.1
   00000049.649.6048.1
   00000049.949.9048.1
   00000050.250.2048.1
   00000050.450.4048.1
   00000049.349.3048.1
   00000049.649.6048.1
   0000005050048.1
   00000049.949.9048.1
   00000049.549.5048.1
   00000049.349.3048.1
   00000050.250.2048.1

券商虧損排行 - 2024/03/26

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.87%-51.6-2.1-49.541561549.249.349.148.1
  -2.55%-22.7-0.3-22.41718149.449.449.148.1
  -1.50%-22.3-0.2-22.116301449.449.449.448.1
  -3.54%-19.4-0.8-18.61011149.849.949.148.1
  -2.17%-11.70-11.71011049.149.149.348.1
  -2.71%-10.70-10.788049.449.4048.1
  -2.66%-6.60-6.655049.449.449.648.1
  -2.46%-6.10-6.155049.349.3048.1
  -1.94%-5.70-5.76604949048.1
  -2.04%-50-555049.149.1048.1
  -1.97%-4.80-4.85504949048.1
  -1.86%-4.60-4.65504949048.1
  -1.74%-4.30-4.355048.948.9048.1
  -2.86%-4.30-4.333049.549.5048.1
  -2.11%-4.20-4.244049.149.1048.1
  -3.66%-3.70-3.722049.949.9048.1
  -2.30%-3.40-3.433049.249.2048.1
  -2.29%-3.40-3.433049.249.2048.1
  -2.27%-3.40-3.433049.249.2048.1
  -3.17%-3.20-3.222049.649.6048.1
  -2.11%-3.10-3.133049.149.1048.1
  -2.04%-30-333049.149.1048.1
  -2.04%-30-333049.149.1048.1
  -3.03%-30-322049.649.6048.1
  -1.87%-2.80-2.83304949048.1
  -2.73%-2.70-2.712049.449.449.248.1
  -1.81%-2.70-2.733048.948.9048.1
  -2.58%-2.60-2.622049.349.3048.1
  -2.54%-2.50-2.522049.349.3048.1
  -2.54%-2.50-2.522049.349.3048.1
  -2.39%-2.40-2.412049.349.249.648.1
  -2.34%-2.30-2.322049.249.2048.1
  -1.56%-2.30.1-2.423149.349.349.448.1
  -2.24%-2.20-2.222049.249.2048.1
  -2.24%-2.20-2.222049.249.2048.1
  -2.24%-2.20-2.222049.249.2048.1
  -2.14%-2.10-2.122049.149.1048.1
  -2.14%-2.10-2.122049.149.1048.1
  -2.14%-2.10-2.122049.149.1048.1
  -2.04%-20-222049.149.1048.1
  -0.49%-1.90.7-2.718649.449.449.548.1
  -1.95%-1.90-1.92204949048.1
  -1.94%-1.90-1.92204949048.1
  -0.09%-1.8-9.17.2-7354249.249.349.148.1
  -1.84%-1.80-1.82204949048.1
  -3.61%-1.80-1.811049.949.9048.1
  -3.51%-1.80-1.811049.849.8048.1
  -3.03%-1.50-1.511049.649.6048.1
  -2.84%-1.40-1.411049.549.5048.1
  -2.83%-1.40-1.411049.549.5048.1
中化生魚油原料藥產能倍增最快年底過美認證 明年營收再登高Anue鉅亨-2022/11/14
年度傑出生技產業獎 中化生、藥華藥入列Anue鉅亨-2022/07/22
〈中國限電〉中印限電危機原料藥再度供給失衡 中化生、台耀迎轉單潮Anue鉅亨-2021/10/07
中化生 相關文章